Navigation Links
Provigil Patent Extension Accorded To Cephalon

Cephalon has been accorded a further six months of patent extension by the FDA for its pediatric sleep disorder treatment medication//, Provigil.

Cephlaon had complied with the terms of an explicit written request that entailed the provision of clinical studies data after studying the effects of provigil on pediatric patients.

Cephalon has settled the ‘provogil’patent infringement litigation with four generic firms, and under this settlement, each of the four defendants will have a non-exclusive royalty bearing right to market and sell a generic version of Provigil in the US, due to become effective in April 2012.


'"/>




Page: 1

Related medicine news :

1. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
2. HIV Patients Opposes Patenting Of AIDS Drug
3. AIDS Sufferers Protest against Proposed Patent for Tenofovir
4. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
5. Venus Remedies Files 5th International Patent Application
6. US Court Rules Against Lupin in Ramipril Patent Case
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
9. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
10. A Patented Device for Rapid Diagnosis of Diseases
11. Drop Patent Petition, Activists Ask Novartis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Duchenne muscular dystrophy, and funding for Duchenne research, participated in the April 25 ... Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott Conference Center ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Society ... year, reproductive endocrinologists are required to report in vitro fertilization (IVF) ... dedicated to the practice of assisted reproductive technologies in the United States. ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... The ... the workforce is aging – meaning that there is an urgent need for highly ... and interactive training solution, delivering a multi-pronged approach to train and retain care managers, ...
(Date:4/28/2016)... ... , ... Monthly subscription boxes are all the rage, and "My Subscription Addiction" ... ZEN BOX , the aromatherapy subscription box. , ZEN BOX delivers three new essential ... and one Zen Blend (like immune boost, sublime sleep or de-stress blends) Each ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 , Net Sales of ... basis over the prior year period, and an increase of ... , Diluted EPS for the first quarter were $0.52 reported, ... $2.00 adjusted, an increase of 29.9% over the prior year ... adjusted earnings guidance for 2016 Zimmer Biomet Holdings, ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... Calif. , April 28, 2016 /PRNewswire/ ... Validation Lifecycle Management Solutions (VLMS) today announced ... and services for sufferers of chronic kidney ... System to manage their corporate validation process. ... seeking a software solution to manage their ...
Breaking Medicine Technology: